Factors associated to chronic kidney disease in people living with HIV/AIDS

Priscila Silva Pontes1, Antonio Ruffino-Netto2, Luciana Kusumota1

  • 1Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.

Insights

Systemic Arterial Hypertension and nephrotoxic antiretrovirals increase chronic kidney disease risk in people living with HIV (PLHIV). Younger age (<40) is protective. Understanding these factors aids clinical decisions for PLHIV.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Epidemiology

Background:

  • Chronic kidney disease (CKD) is a significant comorbidity in people living with HIV (PLHIV).
  • Identifying CKD risk factors in PLHIV is crucial for effective management and prevention strategies.
  • Previous studies suggest various factors contribute to CKD in this population, but specific associations require further investigation.

Purpose of the Study:

  • To analyze the factors associated with chronic kidney disease in people living with HIV (PLHIV).
  • To identify specific risk and protective factors for CKD in a cohort of PLHIV in Brazil.
  • To inform clinical practice and public health interventions for PLHIV at risk of renal dysfunction.

Main Methods:

  • A paired case-control study design was employed, including 17 cases and 68 controls (4 controls per case).
  • Data were collected from medical records of PLHIV attending a specialized care service in Southeastern Brazil.
  • Statistical analyses included Pearson's chi-square test, Fisher's exact test, and logistic regression to determine Odds Ratios (OR) and 95% Confidence Intervals (CI).

Main Results:

  • Systemic Arterial Hypertension was significantly associated with CKD in PLHIV [OR=5.8, p=0.001].
  • Use of nephrotoxic antiretrovirals in previous therapeutic regimens was also linked to increased CKD risk [OR=3.3, p=0.028].
  • Age below 40 years was identified as a protective factor against CKD [OR=0.122, p=0.022].

Conclusions:

  • PLHIV exhibit multi-factorial exposure associated with chronic kidney disease.
  • Identifying hypertension and nephrotoxic antiretroviral use as key risk factors aids in early detection and intervention.
  • Knowledge of these factors supports clinical decision-making for health professionals managing PLHIV, aiming to prevent or manage renal dysfunction.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
436
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
427
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
321
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
246
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
198
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
701